{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:47Z","timestamp":1792190507232,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"31","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.1038\/s41388-026-03874-x","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:04:11Z","timestamp":1782993851000},"page":"3258-3272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1\/CD44-dependent macrophage polarization"],"prefix":"10.1038","volume":"45","author":[{"given":"Qingfu","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-282X","authenticated-orcid":false,"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-5400","authenticated-orcid":false,"given":"Tiemin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"3874_CR1","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"M Vithayathil","year":"2022","unstructured":"Vithayathil M, Khan SA. Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol. 2022;77:1690\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2022.07.022.","journal-title":"J Hepatol"},{"key":"3874_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"3874_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:353\u201363. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.009.","journal-title":"J Hepatol"},{"key":"3874_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise. Oncologist. 2016;21:594\u20139. https:\/\/doi.org\/10.1634\/theoncologist.2015-0446.","journal-title":"Oncologist"},{"key":"3874_CR5","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"key":"3874_CR6","doi-asserted-by":"publisher","first-page":"280.","DOI":"10.1038\/s41575-022-00616-8","volume":"19","author":"J Hindson","year":"2022","unstructured":"Hindson J. Gemcitabine and cisplatin plus immunotherapy in advanced biliary tract cancer: a phase II study. Nat Rev Gastroenterol Hepatol. 2022;19:280. https:\/\/doi.org\/10.1038\/s41575-022-00616-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3874_CR7","doi-asserted-by":"publisher","first-page":"305.","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7:305. https:\/\/doi.org\/10.1038\/s41392-022-01151-3.","journal-title":"Signal Transduct Target Ther"},{"key":"3874_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380. https:\/\/doi.org\/10.1038\/s41586-019-1678-1.","journal-title":"Nature"},{"key":"3874_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:85. https:\/\/doi.org\/10.1186\/s13059-021-02308-z.","journal-title":"Genome Biol"},{"key":"3874_CR10","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.7150\/ijbs.73398","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang J, Luo L, Zhao C, Li X, Wang Z, Zeng Z, et al. A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFR\u03b2 signaling drives clear cell renal cell carcinoma progression. Int J Biol Sci. 2022;18:3470\u201383. https:\/\/doi.org\/10.7150\/ijbs.73398.","journal-title":"Int J Biol Sci"},{"key":"3874_CR11","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660\u201377.e10. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.033.","journal-title":"Mol Cell"},{"key":"3874_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330. https:\/\/doi.org\/10.1080\/15548627.2023.2249762.","journal-title":"Autophagy"},{"key":"3874_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity. 2024;57:1105\u201323.e8. https:\/\/doi.org\/10.1016\/j.immuni.2024.04.006.","journal-title":"Immunity"},{"key":"3874_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02940-w","volume":"42","author":"F Ghadyani","year":"2025","unstructured":"Ghadyani F, Zandi P, Ghafouri-Fard S. Histone lactylation: a new target for overcoming immune evasion and therapy resistance. Med Oncol. 2025;42:399. https:\/\/doi.org\/10.1007\/s12032-025-02940-w.","journal-title":"Med Oncol"},{"key":"3874_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01856-1","volume":"22","author":"B Xie","year":"2023","unstructured":"Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M, et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023;22:151. https:\/\/doi.org\/10.1186\/s12943-023-01856-1.","journal-title":"Mol Cancer"},{"key":"3874_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90. https:\/\/doi.org\/10.1186\/s12943-024-02008-9.","journal-title":"Mol Cancer"},{"key":"3874_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2024.04.010","volume":"81","author":"L Yang","year":"2024","unstructured":"Yang L, Niu K, Wang J, Shen W, Jiang R, Liu L, et al. Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD. J Hepatol. 2024;81:651\u201366. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.010.","journal-title":"J Hepatol"},{"key":"3874_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510483","volume":"13","author":"XT Huang","year":"2025","unstructured":"Huang XT, Chen J, Zhu EL, Ma MJ, Yu YY, Zhu YQ, et al. Positive feedback loop of histone lactylation-driven HNRNPC promotes autophagy to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Adv Sci. 2025;13:e10483. https:\/\/doi.org\/10.1002\/advs.202510483.","journal-title":"Adv Sci"},{"key":"3874_CR19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.immuni.2019.11.008","volume":"51","author":"G Notarangelo","year":"2019","unstructured":"Notarangelo G, Haigis MC. Sweet temptation: from sugar metabolism to gene regulation. Immunity. 2019;51:980\u20131. https:\/\/doi.org\/10.1016\/j.immuni.2019.11.008.","journal-title":"Immunity"},{"key":"3874_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ijom.2021.07.022","volume":"51","author":"X Cai","year":"2022","unstructured":"Cai X, Zhang H, Li T. The role of SPP1 as a prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma. Int J Oral Maxillofac Surg. 2022;51:732\u201341. https:\/\/doi.org\/10.1016\/j.ijom.2021.07.022.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"3874_CR21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1136\/gutjnl-2024-334361","volume":"74","author":"J Yang","year":"2025","unstructured":"Yang J, Yu X, Xiao M, Xu H, Tan Z, Lei Y, et al. Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer. Gut. 2025;74:1859\u201372. https:\/\/doi.org\/10.1136\/gutjnl-2024-334361.","journal-title":"Gut"},{"key":"3874_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, et al. Lactylation in cancer progression and drug resistance. Drug Resist Updat. 2025;81:101248. https:\/\/doi.org\/10.1016\/j.drup.2025.101248.","journal-title":"Drug Resist Updat"},{"key":"3874_CR23","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1158\/1078-0432.CCR-23-1441","volume":"29","author":"K Chaudagar","year":"2023","unstructured":"Chaudagar K, Hieromnimon HM, Kelley A, Labadie B, Shafran J, Rameshbabu S, et al. Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN\/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis. Clin Cancer Res. 2023;29:4930\u201340. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1441.","journal-title":"Clin Cancer Res"},{"key":"3874_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501238","volume":"12","author":"G Wu","year":"2025","unstructured":"Wu G, Cheng H, Yin J, Zheng Y, Shi H, Pan B, et al. NDRG1-driven lactate accumulation promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment. Adv Sci. 2025;12:e01238. https:\/\/doi.org\/10.1002\/advs.202501238.","journal-title":"Adv Sci"},{"key":"3874_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114697","volume":"43","author":"Z Luo","year":"2024","unstructured":"Luo Z, Mei J, Wang X, Wang R, He Z, Geffen Y, et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Rep. 2024;43:114697. https:\/\/doi.org\/10.1016\/j.celrep.2024.114697.","journal-title":"Cell Rep"},{"key":"3874_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30:36\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2019.06.001.","journal-title":"Cell Metab"},{"key":"3874_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02269-y","volume":"24","author":"X Xie","year":"2025","unstructured":"Xie X, Liu W, Yuan Z, Chen H, Mao W. Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications. Mol Cancer. 2025;24:71. https:\/\/doi.org\/10.1186\/s12943-025-02269-y.","journal-title":"Mol Cancer"},{"key":"3874_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI187024","volume":"135","author":"K Sun","year":"2025","unstructured":"Sun K, Zhang X, Shi J, Huang J, Wang S, Li X, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025;135:e187024. https:\/\/doi.org\/10.1172\/JCI187024.","journal-title":"J Clin Invest"},{"key":"3874_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413095","volume":"12","author":"J Cai","year":"2025","unstructured":"Cai J, Zhang P, Cai Y, Zhu G, Chen S, Song L, et al. Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma. Adv Sci. 2025;12:e2413095. https:\/\/doi.org\/10.1002\/advs.202413095.","journal-title":"Adv Sci"},{"key":"3874_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41418-025-01554-z","volume":"33","author":"Y Tang","year":"2025","unstructured":"Tang Y, Li Y, Yang X, Lu T, Wang X, Li Z, et al. Intestinal metabolite TMAO promotes CKD progression by stimulating macrophage M2 polarization through histone H4 lysine 12 lactylation. Cell Death Differ. 2025;33:314\u201326. https:\/\/doi.org\/10.1038\/s41418-025-01554-z.","journal-title":"Cell Death Differ"},{"key":"3874_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.yexcr.2017.08.028","volume":"359","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Du W, Chen Z, Xiang C. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma. Exp Cell Res. 2017;359:449\u201357. https:\/\/doi.org\/10.1016\/j.yexcr.2017.08.028.","journal-title":"Exp Cell Res"},{"key":"3874_CR32","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41416-024-02683-x","volume":"130","author":"C Wang","year":"2024","unstructured":"Wang C, Li Y, Wang L, Han Y, Gao X, Li T, et al. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration. Br J Cancer. 2024;130:1770\u201382. https:\/\/doi.org\/10.1038\/s41416-024-02683-x.","journal-title":"Br J Cancer"},{"key":"3874_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114906","volume":"160","author":"L Hou","year":"2025","unstructured":"Hou L, Jiang M, Li Y, Cheng J, Liu F, Han X, et al. Targeting SPP1(+) macrophages via the SPP1-CD44 axis reveals a key mechanism of immune suppression and tumor progression in ovarian cancer. Int Immunopharmacol. 2025;160:114906. https:\/\/doi.org\/10.1016\/j.intimp.2025.114906.","journal-title":"Int Immunopharmacol"},{"key":"3874_CR34","doi-asserted-by":"publisher","unstructured":"Zhang S, Hu Y, Zhou Z, Lv G, Zhang C, Guo Y, et al. ZEB1 promotes chemoimmunotherapy resistance in pancreatic cancer models by downregulating chromatin acetylation of CXCL16. J Clin Invest. 2025;135. https:\/\/doi.org\/10.1172\/JCI195970.","DOI":"10.1172\/JCI195970"},{"key":"3874_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"TY Zhu","year":"2023","unstructured":"Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11:62. https:\/\/doi.org\/10.1186\/s40364-023-00499-0.","journal-title":"Biomark Res"},{"key":"3874_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506529","volume":"12","author":"T Huang","year":"2025","unstructured":"Huang T, You Q, Liu J, Shen X, Huang D, Tao X, et al. WTAP mediated m6A modification stabilizes PDIA3P1 and promotes tumor progression driven by histone lactylation in esophageal squamous cell carcinoma. Adv Sci. 2025;12:e06529. https:\/\/doi.org\/10.1002\/advs.202506529.","journal-title":"Adv Sci"},{"key":"3874_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401399","volume":"11","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci. 2024;11:e2401399. https:\/\/doi.org\/10.1002\/advs.202401399.","journal-title":"Adv Sci"},{"key":"3874_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1604758","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Sun Y, Liu X. Identification of lactylation-associated immune and metabolic regulators in bladder cancer via integrated bulk and single-cell transcriptomics. Front Immunol. 2025;16:1604758. https:\/\/doi.org\/10.3389\/fimmu.2025.1604758.","journal-title":"Front Immunol"},{"key":"3874_CR39","doi-asserted-by":"publisher","unstructured":"Gajanan A, Magar VK, Morya KC, Noh Molecular crosstalk between RUNX2 and HIF-1\u03b1 in osteosarcoma: implications for angiogenesis, metastasis, and therapy resistance. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26157642.","DOI":"10.3390\/ijms26157642"},{"key":"3874_CR40","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","volume":"33","author":"ME Moreno-Fernandez","year":"2021","unstructured":"Moreno-Fernandez ME, Giles DA, Oates JR, Chan CC, Damen MSMA, Doll JR, et al. PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. Cell Metab. 2021;33:1187\u2013204.e9. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.018.","journal-title":"Cell Metab"},{"key":"3874_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112686","volume":"147","author":"MA Altinoz","year":"2022","unstructured":"Altinoz MA, Ozpinar A. Oxamate targeting aggressive cancers with special emphasis to brain tumors. Biomed Pharmacother. 2022;147:112686. https:\/\/doi.org\/10.1016\/j.biopha.2022.112686.","journal-title":"Biomed Pharmacother"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03874-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03874-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:01:29Z","timestamp":1785189689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":41,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026,8,18]]}},"alternative-id":["3874"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03874-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of The First Affiliated Hospital of Harbin Medical University and was performed in accordance with the principles outlined in the Helsinki Declaration and in compliance with relevant laws and institutional guidelines (Approval No. IRB-AF\/SC-12\/03.0). The privacy rights of participants have been observed and all participants provided informed consent. The animal experiments were reviewed and approved by the Animal Experiment Ethics Committee of The First Affiliated Hospital of Harbin Medical University (Approval No. 2023170).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}